Supplier Type
- Reagent
- Trader
- Manufacturer
Supplier Region
- Mumbai(29)
- Maharashtra(5)
- Hyderabad(6)
- Gujarat(21)
- Ahmedabad(7)
- Uttar Pradesh(3)
- Punjab(1)
- Vadodara(6)
- Telangana(3)
- Tamil Nadu(1)
- New Delhi(1)
- Pune(4)
- Nagpur(2)
- Delhi(7)
- Bangalore(1)
- Haryana(3)
- Karnataka(1)
Purity
- NLT 95%
- more than 90%
- min 99.0%
- Greater than 99%
- Greater than 98%
- 99.55%
- 99% Minimum
- >99%
- > 99%
- 99%
- 99 %
- 99
- 98%
- >98%
- 97.84%
- 97%
- 96.40%
- 96.00%
- 96.00 % Min
- 96%
- 95.00%
- 95.00 % Min
- >95%
- 93.00%
- 93.0 % Min
- >92%
- 90-95%
- 90%
- >90%
- 90 % Min.
- 90 % Above
- 70%
- 68.0 % Min
- 65%
- 17%
- 100%
Package
- 25mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1kg
- 5kg
- 10kg
- 25kg
- 1and gm
- 1MT
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 50mg
- 250250 mg.
-
Nitrofurazone Compound, Non prescription
-
Nitrofurazone
59-87-0
-
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline)
391860-73-4
-
(S)-1-(2-Amino-5-chlorophenyl)-1-(trifluoromethyl)-3-cyclopropyl-2-propyn-1-ol
209414-27-7
-
3-Nonen-2-one
14309-57-0
-
N-Deethyl DorzolaMide Hydrochloride
164455-27-0
-
1-[(4-Chlorophenyl)phenylmethyl]-4-[(2-methylphenyl)methyl]piperazine
2725237-43-2
-
HYOSCYAMINE RELATED COMPOUND A HYDROCHLORIDE -
rac-cis Dorzolamide
120279-37-0
-
Imiquimod Related Compound B (25 mg) (1-Isobutyl-1H-imidazo[4,5-c]quinoline 5-oxide)
99010-63-6
Dasakast 70 DASATINIB, Prescription, Treatment: Blood Cancer 302962-49-8
Siemens 6ES7291-8BA20-0XA0 Lithium Non-Rechargeable Battery For Simatic S7-200
2-Butyl-1,3-Diazaspiro-[4,4]non-1-en-4-one hydrochloride 151257-01-1
Fluorescein Sodium Powder USP, Prescription, Treatment: Treat Pain And Inflammation
